Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Emergence of large treatment effects from small trials--reply.

Ioannidis JP, Pereira TV, Horwitz RI.

JAMA. 2013 Feb 27;309(8):768-9. doi: 10.1001/jama.2012.208831. No abstract available.

PMID:
23443435
2.

Large-scale randomized evidence: large, simple trials and overviews of trials.

Peto R, Collins R, Gray R.

J Clin Epidemiol. 1995 Jan;48(1):23-40. Review. No abstract available.

PMID:
7853045
3.

Interpreting treatment effects in randomised trials.

Guyatt GH, Juniper EF, Walter SD, Griffith LE, Goldstein RS.

BMJ. 1998 Feb 28;316(7132):690-3. Review. No abstract available.

4.

Translating statistical findings into plain English.

Pocock SJ, Ware JH.

Lancet. 2009 Jun 6;373(9679):1926-8. doi: 10.1016/S0140-6736(09)60499-2. Epub 2009 Apr 15. Review. No abstract available.

PMID:
19375158
5.

Statistics commentary series: Commentary #5--can it work or does it work? The difference between efficacy and effectiveness trials.

Streiner DL.

J Clin Psychopharmacol. 2014 Dec;34(6):672-4. doi: 10.1097/JCP.0000000000000223. Review. No abstract available.

PMID:
25275674
6.

Statistical issues in interpreting clinical trials.

DeMets DL.

J Intern Med. 2004 May;255(5):529-37. Review.

7.

Pitfalls and biases in the reporting and interpretation of the results of clinical trials.

Parmar MK.

Lung Cancer. 1994 Mar;10 Suppl 1:S143-50. Review.

PMID:
8087503
8.

Is significant relevant? Validity and patient benefit of randomized controlled clinical trials on age-related macular degeneration.

Joussen AM, Lehmacher W, Hilgers RD, Kirchhof B.

Surv Ophthalmol. 2007 May-Jun;52(3):266-78. Review.

PMID:
17472802
9.

Subgroup analysis in randomized controlled trials appeared to be dependent on whether relative or absolute effect measures were used.

Venekamp RP, Rovers MM, Hoes AW, Knol MJ.

J Clin Epidemiol. 2014 Apr;67(4):410-5. doi: 10.1016/j.jclinepi.2013.11.003. Epub 2014 Feb 5. Review.

PMID:
24508145
10.

Other paradigms: better treatments are identified by better trials: the value of randomized phase II studies.

Sharma MR, Maitland ML, Ratain MJ.

Cancer J. 2009 Sep-Oct;15(5):426-30. doi: 10.1097/PPO.0b013e3181b9c5d5. Review.

PMID:
19826363
11.

When is a negative study not negative?

Scott C, Wasserman T.

Int J Radiat Oncol Biol Phys. 1997 Nov 1;39(4):859-61. Review.

PMID:
9369135
12.

[Requirements of patient-oriented clinical-therapeutic research].

Schäfer H.

Dtsch Med Wochenschr. 1997 Dec 5;122(49):1531-6. Review. German. No abstract available.

PMID:
9453920

Supplemental Content

Support Center